MedImmune Ventures, Inc., 10% Owner at CATABASIS PHARMACEUTICALS INC (CATB), bought 1,302,554 shares at $12.00 ($2.7M) on 2015-06-30, disclosed to the SEC on 2015-06-30.
Open-market purchase of $2.7M CATB by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,079,115 | $0 | 0.0% |
| 2 | $12.00 | 223,439 | $2.7M | 100.0% |
| Total | $2.06 avg | 1,302,554 | $2.7M | 100% |
| Filing → |
| GTHX | SELL | 2017-12-05 | $5.3M | — | Filing → |
| GTHX | SELL | 2017-11-22 | $8.0M | — | Filing → |
| GTHX | BUY | 2017-05-24 | $1.1M | — | Filing → |